It should also be noted that VEGFR2 inhibition increased cancer cell size and polylobular nuclear cells, indicating the endomitosis of glioma cells, which is supported by another piece of evidence demonstrating that VEGFR inhibitor induced misalignment of chromosomes and caused delay in M-Phage progression [18]. The gene discussed is KDR; the disease is glioma.